type here...

CATEGORIES

Neurological

LATEST

1...91011Page 10 of 11

TRENDING

EDITORS CHOICE

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

National Institute for Clinical Excellence Recommends QbTest to Aid Diagnosis of ADHD in Youth

Medika Life -
Global Leader in ADHD Objective Testing Improves Access to Care for Patients in the U.S. and UK

Is Alzheimer’s Damage Linked to Deadly Pollution of Babies, Not Old Age?

Pat Farrell PhD -
Alzheimer’s disease isn’t a disease of old age; it begins in infancy, possibly even before birth, because of pollution. Pollution, therefore, initiates the death spiral even before children can walk and talk.

Sheba Medical Center Selects Two Digital Startups for Integration into Newly Expanded Rehabilitation Ward

Medika Life -
Israeli Startups Cognishine and Kemtai Will Begin a Pilot Program at Sheba to Provide Physical, Cognitive and Emotional Rehab Support for Injured Soldiers  ARC Innovation...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories